Sales and Marketing

Showing 15 posts of 11526 posts found.

Roche building

Roche coy on job cut reports

September 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …

Paul Phull joins PharmaVentures

August 31, 2010 Sales and Marketing PharmaVentures, appointment, sales and marketing

Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …

Swiss approval for Novartis’ Tasigna

August 31, 2010 Sales and Marketing Novartis, Tasigna, Tekamlo

Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …

US prescription drug prices rise above inflation

August 27, 2010 Sales and Marketing US, prices

A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …

US court bars stem cell funding

August 26, 2010 Sales and Marketing Obama, Stem cells, US

A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …

Alcon acquisition makes Novartis eyecare leader

August 26, 2010 Sales and Marketing Novartis, ophthalmology

Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …
Velcade

Janssen to appeal against Velcade decision

August 26, 2010 Medical Communications, Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma

Celgene’s Thalidomide has been recommended by NICE for multiple myeloma ahead of Janssen-Cilag’s Velcade. A final appraisal determination says that …

NICE updates guidance for arthritis treatments

August 26, 2010 Sales and Marketing NICE, Roche, rheumatoid arthritis

Five new drugs for rheumatoid arthritis have been given the thumbs up by NICE as second line treatment. Roche’s MabThera, …
Multaq

Multaq given limited approval from NICE

August 25, 2010 Medical Communications, Sales and Marketing Multaq, NICE, Sanofi-Aventis, atrial, dronedarone

NICE has given a restricted approval to Sanofi-Aventis’s Multaq as a second line treatment for atrial fibrillation patients. The guidance …

Avastin patient access scheme too complicated, says NICE

August 25, 2010 Sales and Marketing NICE, avastin, patient access

NICE is set to say no again to Avastin for use in patients with colorectal cancer. Avastin was first launched …

Roche signs $1bn peptide deal with Aileron

August 25, 2010 Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …

Sutent disappoints in lung cancer

August 24, 2010 Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …

Avandia letter misleading, FDA tells Glaxo

August 24, 2010 Sales and Marketing Avandia, GSK

GlaxoSmithKline’s travails over controversial diabetes drug Avandia show no sign of abating as members of a key regulatory panel accused …
PakistanFloodWEB

Pharma provides aid for Pakistan

August 24, 2010 Sales and Marketing GSK, NGO, Novartis, Pakistan, disaster, pharma, relief

 The pharma industry is providing donations to help those affected by the mass flooding across Pakistan. As many as 20 …
The Gateway to Local Adoption Series

Latest content